Quibim

Medical imaging transformed into actionable predictions

Quibim is a portfolio company of APEX Ventures, specializing in AI models for medical imaging. The company raised $50 million in Series A funding in 2025.

Quibim hero image

Shareable draft

Check out Quibim on @MedStartr Today Quibim is a portfolio company of APEX Ventures, specializing in AI models for medical imaging. The company raised $50 million in Series A funding in 2025. #Immunology #Neurology #MetabolicDiseases #CancerOncology #PrecisionMedicineDiagnostics #MedMo #MedStartrVentures

https://www.medstartr.ai/s/7gCp1XxY6U4

Get Involved in Quibim

1 engagement

How We Help

Problem Statement

The challenge of efficiently and accurately extracting quantitative information from medical images to aid in disease detection, diagnosis, and treatment monitoring.

Core Technology

AI models for medical imaging

Key Differentiators

Provides AI-powered solutions to extract quantitative information from medical images for disease detection, diagnosis, and treatment monitoring.; Transforms medical images into actionable insights.; Offers a QIB platform with a suite of AI models for analyzing various medical image modalities and body regions.; Delivers quantitative biomarkers to enhance diagnostic accuracy and facilitate drug development for diseases such as prostate cancer, Alzheimer's, and multiple sclerosis.

Clinical Focus

Prostate; Brain; Liver; Medical Imaging

Company Info

Business Model: SaaS
Total Funding: Only accessible to MedStartr community members. Join now
Only accessible to MedStartr community members.
Join now
Website: www.quibim.com

Disease Areas

Immunology Neurology Metabolic Diseases Cancer & Oncology

Technologies

Medical ImagingAI & Machine Learning

Clinical & IP

🔬

Clinical Validation

FDA 510(k) cleared: QP-Prostate (lesion detection/diagnosis, March 2025), QP-Brain. Mass General Brigham validation study met superiority endpoint for aided radiologist performance. 350+ peer-reviewed publications including prospective multi-centric trials (4000+ patients for prostate cancer aggressiveness prediction). CE/UKCA/TGA/FDA clearances across product line.

🌐Website

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of Quibim?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.